Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
May 28 2020
« Safety and function of a new pre-vascularized bioartificial pancreas in an allogeneic rat model »...
May 05 2020
Towards a physiological treatment for Type 1 diabetes A new fund raising round for Defymed, to allow...